Today, I’ll be talking about the U.S.dollar. I think this is very important, so please listen up.
Molson Coors Brewing Company
As the weather warms up and capacity restrictions ease at our favorite water holes, this famous Brewmeister has hit our radar as a must buy.
And after expanding their product line, partnering up with Dwayne "The Rock" Johnson, and coming through with a killer earnings announcement, this stock is right on the cusp of a record-setting rally.
The warm summer weather allowed people and restaurants to enjoy outdoor activities safely.
But now with the onset of fall and dropping temperatures, COVID-19 cases are resurging.
In fact, four sectors are going to be hit hard this fall and winter.
So D.R.'s showing you the six stocks to avoid now in his "Winter Survival Plan" to ensure your portfolio is well-insulated….
The Dow Jones Industrial Average soared over 200 points this morning as optimism over the coronavirus prevailed.
Fears of the virus' economic consequences have dwindled.
But there are murmurs that the ongoing outbreak could interfere with commitments by China to honor its deal to purchase U.S. agricultural products.
The latest figures show that cases have surpassed 44,500 and more than 1,110 deaths.
Together, we stand at the cusp of a truly unique opportunity. Never before have everyday investors had such early access to the birth of an entirely new industry.
And never before has a new industry emerged with well over 260 million customers already in place – spending nearly $350 billion a year in both legal and black market sales.
Compare that figure to the current $20 billion legal cannabis market and you can clearly see a wealth-building opportunity that has a lot of room to run.
At the pace that recreational use is getting legalized, that $20 billion market has to grow at 80% per year just to keep up.
Revenue surging at 80% per year for a brand-new industry is completely unprecedented.
With much of the road paved with existing demand, and because of the current lack of federal regulations, everyday investors like you have the chance to get in on the ground floor.
It's a truly historic opportunity – and I get the pleasure of helping you make the most of it.
Here's how I plan to do that for you… Full Story
Recently, cannabis stocks have faced some headwinds.
But there are always winners and losers across the market.
And, today, we're bringing you a winner. In fact, it's one of the top CBD oil stocks to buy now.
We've talked before about the "vaping crisis" – a kind of lung syndrome sickening and, in some cases, killing, users of vaporized cannabis and nicotine.
So far, it seems that illicit, black market products are making people sick, but the crisis is beginning to weigh on the legal market.
But, just as nature abhors a vacuum, markets don't much care for 'em, either.
But nature abhors a vacuum - and markets don't much care for 'em, either. It's only natural that support is coalescing around other lucrative cannabis market segments, opening up more diverse opportunities for investors... Full Story
Last week, The New York Times ran an editorial piece with the headline, "Do We Really Want a Microsoft of Marijuana?"
The author of the report, Christopher Caldwell, opines that the SAFE Banking Act would disproportionately help giant operators at the expense of smaller companies. That, in turn, would usher in a dystopian future in which multinational businesses develop new flavors and products to turn America's children into a nation of potheads.
I read a lot of wrongheaded news and misinformation pieces about cannabis, but this one may be the winner in terms of getting things wrong.
In barely 1,000 words, the author makes three points that need addressing.
The first is the overall theme. We absolutely want a Microsoft of marijuana!
We want one as investors, as consumers, and as supporters of the industry. Microsoft has its flaws, but overall, a lot of people have benefited from the success of the tech company. We can partially thank Microsoft for reliable computer operating systems, sophisticated spreadsheets, and cheap cloud computing that allows us to share our ideas in real time all over the world.
Do we want a company with the resources to improve the accuracy and speed of cannabis testing, one that can grow more precise strains for medical patients, and one that can perfect security and seed-to-sale tracking?
I want those things. So do you.
And he doesn't know it yet, but so does Mr. Caldwell. Here's why… Full Story
The Dow Jones today will stay flat since President Trump hinted at more tariffs over Memorial Day weekend.
Alongside a trade war, we also have beer wars, oil supply shrinkage, and a big auto industry merger moving the DJIA.
Recreational marijuana legalization got a lot of media ink in 2018 – for good reason.
But a separate cannabis market focused on healing, medicinal uses, and wellness is also exploding.